Many chemotherapeutic agents are used in the treatment of breast cancer, including Tamoxifen (ER-positive breast cancer), Pertuzumab (HER2-overexpressing breast cancer) and Voxtalisib (HR+/HER- advanced breast cancer) (Bhushan, Gonsalves & Menon, 2021). The gene discussed is ERBB2; the disease is breast cancer.